This work was aimed at determining the cardioprotective effect of digitalis glycosides in rat heart, and to relate it with Na+, K+-ATPase inhibition and ERK1/2 activation. Isolated working rat hearts were perfused in the presence of ouabain or digoxin, which were used at concentrations ranging from 10(-8) to 10(-5) M. The hearts were then subjected to 30 minutes of global normothermic ischemia followed by 120 minutes of retrograde reperfusion; irreversible tissue injury was determined on the basis of triphenyltetrazolium chloride staining. Significant cardioprotection was observed with 10(-7) M and 10(-5) M ouabain (ischemic injury averaged 7.0 +/- 3.5% and 8.3 +/- 0.6% versus 37.3 +/- 2.0% in controls. P < 0.01 in each case). Hearts treated with digoxin showed decreased ischemic injury at 10(-6) M and 10(-5) M (18.0 +/- 1.5% and 14.2 +/- 1.0%, P < 0.01 versus control in both cases). In parallel experiments, ERK2 phosphorylation was increased by 10(-7) to 10(-5) M ouabain, while ERK1 and ERK2 phosphorylation was increased by 10(-6) to 10(-5) M digoxin. The cardioprotective effect was not related to Na+, K+-ATPase inhibition, since Rb+ uptake was not significantly different between control and treated hearts.

Cardioprotection by ouabain and digoxin in perfused rat hearts

D'URSO, GIUSEPPINA;FRASCARELLI, SABINA;ZUCCHI, RICCARDO;BIVER, TARITA;MONTALI, UMBERTO
2008

Abstract

This work was aimed at determining the cardioprotective effect of digitalis glycosides in rat heart, and to relate it with Na+, K+-ATPase inhibition and ERK1/2 activation. Isolated working rat hearts were perfused in the presence of ouabain or digoxin, which were used at concentrations ranging from 10(-8) to 10(-5) M. The hearts were then subjected to 30 minutes of global normothermic ischemia followed by 120 minutes of retrograde reperfusion; irreversible tissue injury was determined on the basis of triphenyltetrazolium chloride staining. Significant cardioprotection was observed with 10(-7) M and 10(-5) M ouabain (ischemic injury averaged 7.0 +/- 3.5% and 8.3 +/- 0.6% versus 37.3 +/- 2.0% in controls. P < 0.01 in each case). Hearts treated with digoxin showed decreased ischemic injury at 10(-6) M and 10(-5) M (18.0 +/- 1.5% and 14.2 +/- 1.0%, P < 0.01 versus control in both cases). In parallel experiments, ERK2 phosphorylation was increased by 10(-7) to 10(-5) M ouabain, while ERK1 and ERK2 phosphorylation was increased by 10(-6) to 10(-5) M digoxin. The cardioprotective effect was not related to Na+, K+-ATPase inhibition, since Rb+ uptake was not significantly different between control and treated hearts.
D'Urso, Giuseppina; Frascarelli, Sabina; Zucchi, Riccardo; Biver, Tarita; Montali, Umberto
File in questo prodotto:
File Dimensione Formato  
379777851630.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 115.34 kB
Formato Adobe PDF
115.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/196837
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 16
social impact